Z

Zealand Pharma
ZEAL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
DKK32.04B
EV
DKK23.89B
Shares Outstanding
71.74M
Beta
0.56

Wall Street View

Analyst Rating
BUY
Analyst Target Price
DKK903.69
P/E 2025E
7.03x
P/Revenue 2025E
4.48x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Zealand Pharma A/S

gainify

Z

Zealand Pharma A/S

ZEAL

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with...

Sector

Healthcare

Industry

Biotechnology

CEO

Steensberg, Adam

Employees

385

IPO Date

2010-11-23

Headquarters

Sydmarken 11, Søborg, Capital Region of Denmark, 2860, Denmark

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.